Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Element Biosciences is a multiomics company focused on developing disruptive genetic analysis tools for the life sciences research and diagnostic markets. The company's flagship product, the AVITI System, is a benchtop sequencer that utilizes proprietary Avidite chemistry to deliver high-quality, cost-effective next-generation sequencing (NGS) and multiomic data. By integrating genomics, transcriptomics, and proteomics into a single workflow, Element enables researchers to gain deeper biological insights with greater flexibility. The company aims to democratize access to advanced biological tools, accelerating discoveries in areas such as oncology, rare diseases, and infectious disease research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Elements.